Strong technical expertise

We have particular expertise in developing technically challenging products such as injectables, complex formulations, unstable compounds and sustained release tablets and capsules.

Focus on niche, higher margin products

When identifying and developing new generic pharmaceutical products, we lookfor products that have a strong market potential and that are in complementary or fast growing therapeutic categories. We also try to identify products for which we would have an advantage in API sourcing, for which we have a particular expertise in the development or manufacturing process, and for which we can expand our offering through line extensions.

Track record of results

In 2007, we received 129 product approvals across a range of therapeutic categories including Anti-Infective, Central Nervous System (CNS), and Alimentary Tract and Metabolism. With a strong pipeline of products pending approval in these and other therapeutic categories, we believe we are well-positioned to continue this trend.